The Canadian dollar rose against most currencies on Thursday, after the release of positive economic data, and amid focus on Omicron's latest updates.
The World Health Organization said that Omicron's ability to spread remains unknow compared to Delta.
The US Food and Drug Administration has officially approved Pfizer's antiviral pills for patients aged 12 years and over who are at risk of developing severe symptoms.
The FDA also gave the emergency license to a drug by Merck that prevents 30% of hospitalization and developing severe symptoms.
The White House stated that Pfizer's drug will not be available in abundance before the end of next summer.
The Canadian GDP reading showed a growth of 0.8% last month, on par with analysts' forecasts.
As of 16:14 GMT, CAD/USD rose 0.1% to 0.7800, after hitting a high of 0.7808 and a low of 0.7779.